Logo wahanariau.com
  2. New jersey

New jersey

Index
Globenewswire

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

Jumat, 02 Oktober 2026 - 21:27:28 Wib
Globenewswire

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Jumat, 02 Oktober 2026 - 21:26:38 Wib
Globenewswire

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Selasa, 29 September 2026 - 22:34:15 Wib
Globenewswire

DALI Lighting Awards 2027 Resmi Membuka Pendaftaran Karya

Jumat, 25 September 2026 - 21:20:36 Wib
Globenewswire

Teva Releases Q3 2026 Aide Memoire

Kamis, 24 September 2026 - 22:18:05 Wib
Globenewswire

Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET

Kamis, 24 September 2026 - 22:17:25 Wib
Globenewswire

DALI Lighting Awards 2027 Open for Entries

Rabu, 23 September 2026 - 23:33:58 Wib
Globenewswire

DALI Alliance Mengumumkan Rencana Penyelenggaraan KTT + Pameran Global DALI 27 Perdana

Rabu, 23 September 2026 - 23:31:49 Wib
Globenewswire

DALI Alliance Announces DALI 27 Inaugural Global Summit + Expo

Selasa, 22 September 2026 - 21:04:29 Wib
Globenewswire

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Senin, 21 September 2026 - 20:24:09 Wib
Globenewswire

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Senin, 21 September 2026 - 20:23:18 Wib
Globenewswire

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Senin, 21 September 2026 - 20:22:15 Wib
Globenewswire

Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

Rabu, 16 September 2026 - 22:54:54 Wib
Globenewswire

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Senin, 14 September 2026 - 21:28:13 Wib
Globenewswire

Global Insured Catastrophe Losses Now Expected to Average $171 Billion Annually, Verisk Finds

Selasa, 01 September 2026 - 22:28:34 Wib
Globenewswire

Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

Selasa, 01 September 2026 - 22:17:53 Wib
Globenewswire

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

Selasa, 01 September 2026 - 22:16:20 Wib
Globenewswire

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Rabu, 19 Agustus 2026 - 21:48:36 Wib
Globenewswire

Vislink Reports Second Quarter 2026 Financial Results

Senin, 17 Agustus 2026 - 21:23:54 Wib
Globenewswire

World Champions Crowned at Pearson’s Certiport 2026 Microsoft Office Specialist Competition

Kamis, 30 Juli 2026 - 20:43:21 Wib
Globenewswire

Pearson Names Certiport 2026 Adobe Certified Professional World Champion

Kamis, 30 Juli 2026 - 20:42:34 Wib
Globenewswire

Chemical Marketing & Economics honors LyondellBasell CEO Peter Vanacker with STEM Leadership Award for Corporate Reinvention

Selasa, 28 Juli 2026 - 20:35:47 Wib
Globenewswire

Datacolor Introduces Connected Color Intelligence with Launch of Textile Lab Manager

Jumat, 17 Juli 2026 - 08:32:34 Wib
Globenewswire

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Rabu, 01 Juli 2026 - 21:57:11 Wib
Globenewswire

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

Senin, 29 Juni 2026 - 22:31:46 Wib